Glossary

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Term Definition
AHPPC

Australian Health Protection Principal Committee

AIDS

Acquired Immunodeficiency Syndrome

Anonymous delinked tests

Testing of samples which have been irreversibly de-identified 

ARTG

Australian Register of Therapeutic Goods

ASHM

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine

BBVSS

Blood Borne Viruses and Sexually Transmissible Infections Standing Committee

bDNA

Branched chain DNA assay 

BED assay

An enzyme immune assay (EIA) that detects increasing levels of anti-HIV IgG after seroconversion and can be used for detecting recent HIV infection. It uses a branched peptide that includes gp41 immunodominant sequences from HIV-1 subtypes B, E, and D. Developed by the US Centers for Disease Control, the test is approved in the US for use for surveillance purposes only. 

CALD

Culturally and linguistically diverse background 

CALD

Culturally and Linguistically Diverse

CDNA

Communicable Diseases Network of Australia 

Compulsory testing

Where a person had no choice in being tested e.g. as directed under a public health order 

Confirmatory test

The test that actually defines the anti-HIV status of a sample. Confirmatory testing must occur on each reactive sample.

DoHA

Department of Health and Ageing

EIA

Enzyme immunoassay – test allowing the detection of an antigen-antibody interaction using enzyme activity as the indicator 

 

 ASHM_LOGO_

Development of this site and the 2014 and 2017 revisions of the testing policies was supported by: Australian Government Department of Health and Ageing